With over-4000 pharmaceutical players, China is the second largest pharmaceutical industry globally. Although highly fragmented, global pharma and biopharmaceutical players such as Novartis, Novo Nordisk, and AstraZeneca, have a significant hold capturing at least 8-10Percentage of the market. The market being highly dependent on its distributor ne...

Immuno-oncology is based on the premise that tumors escape detection by the immune system, contributing to their growth and progression. Checkpoint inhibitor pathways act as the checks and balances that allow T-cells to recognize foreign substances or tumors. This global study looks at the immune-oncology therapeutics pipeline for checkpoint inhibi...

Readers of the Lab Manager Magazine were invited to participate in an online survey in August 2015. To qualify, readers were required to play a role in their lab’s purchasing process, be familiar with their labs’ product budgets, and represent a lab that either uses or plans to use products in one or more of the 7 specified categories (instrume...

This research service covers the therapeutics for rheumatic diseases market in the United States from 2009 to 2017, with 2011 as the base year. The focus of this research is on biologics and other treatments prescribed as add-on therapies for rheumatoid arthritis (RA), psoriatic arthritis (PsA), and ankylosing spondylitis (AS); background standard ...

The medical device industry continues to be one of the most vital and dynamic sectors in the United States economy, and it is a leading force in the revolution that is transforming the healthcare system in the United States. However, the industry is undergoing a transition to adapt to new business models that are changing the way care is delivered ...

An analysis of end user investment trends and preferences for healthcare software solutions was carried out on the public and private sectors in South Africa. The research service encompasses a comprehensive PESTLE (Political, Economic, Social, Technology, and Environment) analysis allowing for an accurate assessment of the external factors impacti...

This country specific healthcare IT market analysis looks at the healthcare delivery system structure, financing, resources, expenditure, IT bodies and initiatives, drivers and restraints, market forecasts, price, technology and procurement trends, potential target markets, barriers to entry and key factors for success for new market entrants.

This country specific healthcare IT market analysis looks at the healthcare delivery system structure, financing, resources, expenditure, IT bodies and initiatives, drivers and restraints, market forecasts, price, technology and procurement trends, potential target markets, barriers to entry and key factors for success for new market entrants.

This country specific healthcare IT market analysis looks at the healthcare delivery system structure, financing, resources, expenditure, IT bodies and initiatives, drivers and restraints, market forecasts, price, technology and procurement trends, potential target markets, barriers to entry and key factors for success for new market entrants.